A detailed history of Ubs Oconnor LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Ubs Oconnor LLC holds 22,253 shares of BPMC stock, worth $2.13 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
22,253
Holding current value
$2.13 Million
% of portfolio
0.14%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$84.1 - $120.5 $497,030 - $712,155
5,910 Added 36.16%
22,253 $2.06 Million
Q2 2024

Aug 14, 2024

SELL
$85.18 - $108.78 $141,143 - $180,248
-1,657 Reduced 9.21%
16,343 $1.76 Million
Q1 2024

May 15, 2024

BUY
$73.17 - $99.79 $658,530 - $898,110
9,000 Added 100.0%
18,000 $1.71 Million
Q4 2023

Feb 14, 2024

SELL
$43.96 - $92.84 $1.76 Million - $3.71 Million
-39,984 Reduced 81.63%
9,000 $830,000
Q3 2023

Nov 14, 2023

BUY
$46.9 - $66.0 $56,280 - $79,200
1,200 Added 2.51%
48,984 $2.46 Million
Q2 2023

Aug 14, 2023

BUY
$42.2 - $66.37 $2.02 Million - $3.17 Million
47,784 New
47,784 $3.02 Billion
Q1 2023

May 15, 2023

BUY
$37.97 - $50.0 $289,597 - $381,350
7,627 Added 18.33%
49,233 $2.21 Million
Q4 2022

Feb 14, 2023

BUY
$41.06 - $66.48 $1.71 Million - $2.77 Million
41,606 New
41,606 $0
Q2 2022

Aug 12, 2022

BUY
$45.23 - $70.15 $198,559 - $307,958
4,390 Added 27.44%
20,390 $1.03 Million
Q1 2022

May 16, 2022

BUY
$54.1 - $110.08 $865,600 - $1.76 Million
16,000 New
16,000 $1.02 Million

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.71B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Ubs Oconnor LLC Portfolio

Follow Ubs Oconnor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.